/
/
/

Mankind Pharma Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)2,372.00
Volume (₹)1.36 L
High (₹)2,372.00
Upper Circuit2,609.20
Low (₹)2,328.10
Lower Circuit2,134.80
Prev Close2,372.00
52W High (₹)2,642.00
Price2,341.30
52W Low (₹)1,909.70

Share Market Cap & Key Ratios Overview

M.Cap (₹)97850.40 Cr
Div. Yield (%)0.04
PE Ratio47.90
Debt to Equity0.37
Price to Book5.09
Book Value393.72
EPS (TTM)49.45
Face Value1.00
ROE (%)12.69

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
LTP
1W Low
1W High
Market cap (₹)
1752.4-7.6 (-0.43%)
1743.10
1776.60
4,24,466Cr
9108.5-231.5 (-2.48%)
9060
9431.50
2,46,222Cr
4597.4-59.5 (-1.28%)
4551.80
4682
1,76,301Cr
1116.3-1.2 (-0.11%)
1107.30
1139.80
1,12,818Cr
2042.7+6.1 (0.30%)
2007.80
2069.20
1,10,823Cr
1317.7+16.7 (1.28%)
1300.20
1333.30
1,07,447Cr
1231.1+34.1 (2.85%)
1196.90
1250.70
1,03,471Cr
2341.3-27.2 (-1.15%)
2328.10
2426.80
97,850Cr
1677-16 (-0.95%)
1660.10
1715
96,836Cr
1935.9-20.6 (-1.05%)
1925.70
1964.90
89,629Cr

Key Highlights of Mankind Pharma Ltd Balance Sheet

Mankind Pharma Ltd balance sheet discloses shareholders' funds of ₹41.28Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹41.28Cr, and the reserves and surplus of the company is ₹16307.9Cr.

The company has its non-current liabilities with total liabilities of ₹24451.8Cr as of 2026-03-31.

The current liabilities are ₹5473.19Cr as of 2026-03-31. At the same time, current assets are ₹4183.13Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹15472Cr and tangible assets of ₹3925.81Cr, provided in the Mankind Pharma Ltd financial statements.